Monica M. Davis
Role not yet determined Is this you? Add your title
Also affiliated: ECRI Institute (2008); Children's Hospital of Philadelphia (2008–2014); The University of Texas MD Anderson Cancer Center (2004); Loughborough University (2016); University of Alberta (2006–2008); Stockholm University (2010–2013); Saint John Regional Hospital (2007); Horizon Health Network (2007); Drexel University (2008); National Patient Safety Foundation (2005–2009)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Monica M. Davis's research investigates the molecular underpinnings of human diseases, with a recent focus on mitochondrial function in chronic kidney disease and the characterization of a specific genetic disorder related to mitochondrial threonyl-tRNA-synthetase (TARS2). Her work utilizes genetic and molecular approaches to understand disease mechanisms. Davis has published 27 papers, accumulating 612 citations, and holds an h-index of 13. She collaborates with colleagues at the University of Arkansas for Medical Sciences, including Horace J. Spencer, Craig Porter, Rose S.N. Jain, and L. Treas, with whom she has co-authored publications.
Metrics
- h-index: 13
- Publications: 27
- Citations: 622
Selected Publications
-
Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder (2023)
-
Altered mitochondrial respiration in platelets and PBMCs in patients with stages 4 or 5 chronic kidney disease (2023)
Collaboration Network
Top Collaborators
- Altered mitochondrial respiration in platelets and PBMCs in patients with stages 4 or 5 chronic kidney disease
- Altered mitochondrial respiration in platelets and PBMCs in patients with stages 4 or 5 chronic kidney disease
- Altered mitochondrial respiration in platelets and PBMCs in patients with stages 4 or 5 chronic kidney disease
- Altered mitochondrial respiration in platelets and PBMCs in patients with stages 4 or 5 chronic kidney disease
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
- Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder
Similar Researchers
Based on overlapping research topics